Neogen Corporation
NASDAQ:NEOGMedical - Diagnostics & Research
+$0.16 today
- Market cap
- $2.42B
- Beta
- 1.80
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$2.80
Volume 1.79M
Average 2.53M
NEOG Common Stock Issued
Cash raised by issuing new shares.
Neogen CorporationNASDAQ: NEOG
Common Stock Issued · Q1 FY2027 · quarter ended Aug 2026
Common stock issued growth accelerates
Q1 FY2027 common stock issued of $2.2M rose 143.1% year over year, ahead of the -32.9% change in trailing-twelve-month common stock issued. Sequentially, it rose 182.8% from the prior quarter. Over 3 fiscal years it compounded at +10.2% a year.
Context
- Common stock issued amounted to 0.2% of revenue in FY2026, unchanged from a year earlier.
- Common stock issued increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +143.1% holds above the trailing-twelve-month pace of -32.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2026
- 1.6M USD
- Year-over-year change
- -28.6%
- 4-year CAGR
- -33.0%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2026 | 2026-05-31 | 1.6M | -28.6% |
| FY2025 | 2025-05-31 | 2.24M | -8.7% |
| FY2024 | 2024-05-31 | 2.46M | +105.5% |
| FY2023 | 2023-05-31 | 1.2M | -84.9% |
| FY2022 | 2022-05-31 | 7.93M | — |
Common Stock Issued vs competitors
How NEOG compares with its peers on the latest reported figures
- NEOG's LTM Aug 2026 common stock issued of $2.9M is the 4th largest of the 7 companies compared; the peer median is $3.2M.
- Its year-over-year change of -32.9% is the lowest of 4, against a peer median of +657.6%.
- Common stock issued amounts to 0.3% of revenue for NEOG, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $261M | +987.5% | -37.9% | 0.4% | |
| LTM Sep 2026 | $100.42M | +657.6% | +37.7% | 2.2% | |
| LTM Sep 2026 | $6.39M | +22.9% | — | 0.6% | |
| LTM Aug 2026 | $2.9M | -32.9% | +10.2% | 0.3% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NEOG) | $3.2M | +657.6% | -0.1% | 0.2% | |
Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 | FY2026 May 2026 |
|---|---|---|---|---|---|
| Net Income | 48.31M | (22.87M) | (9.42M) | (1.09B) | (7.9M) |
| Depreciation & Amortization | 24.13M | 90.47M | 121.23M | 125.67M | 116.3M |
| Deferred Income Tax | (4.7M) | (19.23M) | (27.42M) | (57.78M) | (24.3M) |
| Stock-Based Compensation | 7.15M | 10.18M | 13.77M | 17.29M | 13.4M |
| Change in Working Capital | (4.42M) | (24.2M) | (72.68M) | (5.93M) | 58.8M |
| Accounts Receivables | (7.8M) | (53.88M) | (20.1M) | 11.64M | 6.8M |
| Inventory | (21.07M) | 9.96M | (55.95M) | (16.12M) | 38.2M |
| Accounts Payables | 20.24M | 18.64M | 13.75M | (402K) | 19.8M |
| Other Working Capital | 4.21M | 1.09M | (10.38M) | (1.05M) | (6M) |
| Other Non-Cash Items | (2.44M) | 6.67M | 9.8M | 1.07B | (73.1M) |
| Operating Cash Flow | 68.04M | 41.03M | 35.26M | 58.24M | 83.2M |
| Capital Expenditures | (24.43M) | (65.76M) | (111.42M) | (104.6M) | (51.3M) |
| Acquisitions (Net) | (38.75M) | 12.55M | 108K | 5.08M | 121.7M |
| Purchases of Investments | (415.89M) | (12.52M) | 0 | 0 | 0 |
| Sales of Investments | 381.84M | 266.77M | 82M | 325K | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 100K |
| Investing Cash Flow | (97.23M) | 201.04M | (29.31M) | (99.2M) | 70.5M |
| Debt Repayment | 0 | (100M) | (420K) | (321K) | (100M) |
| Common Stock Issued | 7.93M | 1.2M | 2.46M | 2.24M | 1.6M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.12M) | (19.28M) | (118K) | (3.52M) | (1M) |
| Financing Cash Flow | 6.81M | (118.08M) | 1.92M | (1.6M) | (99.4M) |
| Effect of Forex Changes | (8.75M) | (5.22M) | (502K) | 942K | 2.2M |
| Net Change in Cash | (31.13M) | 118.77M | 7.37M | (41.61M) | 56.5M |
| Free Cash Flow | 43.61M | (24.73M) | (76.16M) | (46.35M) | 31.9M |
Neogen Corporation
NASDAQ:NEOG
Intrinsic Alpha fair value
Locked
Current Price
$11.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.